8 results
IDSA Algorithm for the Initial Management of Fever and Neutropenia

LOW RISK
 • Antidpated neutropenia < 7
IDSA Algorithm for ... Management of Fever ... stable and no medical ... #neutropenic #fever ... #IDSA #Algorithm
Summary table of types of hypersensitivity reactions. 
Type 1
 - Mediators: lgE
 - Antigen Form: Soluble
Summary table of ... Anaphylaxis, Hay fever ... they activate complement ... types #allergy #table ... #classification
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
, seasonal hay fever ... antigen, leading to complement ... Complement activation ... Hypersensitivity #Types #Classification ... Diagnosis #Reactions #Table
IDSA Algorithm for Neutropenic Fever - Initial Management, Subsequent Management and Prolonged Fever
Figure 1. Initial management
IDSA Algorithm for ... neutropenia < 7 days and clinically ... stable and no medical ... >7 days or • Clinically ... #IDSA #Algorithm
EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus
Clinical Domains:
 • Constitutional domain: Fever
 • Cutaneous domain: Non-scarring
EULAR/ACR Classification ... Erythematosus Clinical ... Constitutional domain: Fever ... anticoagulant • Complement ... #EULARACR #Classification
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... weight loss, and fever ... anti-Smith Ab, low complements ... Skin Disease Classification ... to: Arthritis, Fever
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
or family - Ever ... metabolic equivalent able ... event, follow ACC algorithm ... Change in clinical ... Stable patients
Coccidioidomycosis (Valley Fever) - Diagnosis and Management Summary

WHAT?
 • Coccidioidomycosis due to Coccidioides immitis or Coccidioides
Coccidioidomycosis (Valley Fever ... known as valley fever ... analysis using complement ... TREATMENT: Clinically ... stable patients